DL Edelstein, FM Giardiello, A Basiri, LM Hylind… - Familial cancer, 2011 - Springer ... In addition, evaluation by immunohistochemistry of intestinalpolyps in mice heterozygous for the multiple intestinal neoplasia gene (Min/?) (the murine model of human familial adenomatous polyposis) revealed an increase and redistribution of VEGF-A in the proximity of those ... Related articles - All 3 versions
[PDF] from peerproject.euE Maher, M Nahorski, D Lim, L Martin, J Gille… - 2011 - repository.peerproject.eu ... Gastrointestinal polyposis with esophageal polyposis is useful for early diagnosis of Cowden's ... Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality ... Implications of familial colorectal cancer risk profiles and microsatellite instability status ... Related articles
RJ Cruz Jr, G Costa, GJ Bond, K Soltys… - …, 2011 - journals.lww.com ... of visceral transplantation has added a new therapeutic dimension to the conventional algorithmic management of patients with familial adenomatous polyposis (FAP) ( 1, 2 ). Different modalities of the procedure are often required to rescue patients with intestinal failure and ... Related articles - All 4 versions
AT Chan - Cancer Prevention Research, 2011 - AACR ... 2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. ... 56:710–4. Abstract/FREE Full Text. 16.↵: Barnes CJ,; Lee M. . Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min ... Related articles - All 3 versions
T Wang, KG Yeoh… - Gut, 2011 - gut.bmj.com ... receptor 5 (Lgr5), Musashi-1, Bmi1 and CD44, and the severity of intestinalpolyposis in Apc 1322T mice, which had a submaximal level of active/nuclear β-catenin. Their findings deserve to be validated in clinical specimens. Patients with familial adenomatous polyposis (FAP ...